$11.14
-0.45-3.88%
At close: -
$11.14
00.00%
After Hours: Nov 15, 5:35 PM EDT
Comments
Loading...
Y-mAbs Therapeutics (NASDAQ:YMAB) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Data brought to you by Benzinga APIs
FAQ
What is the most recent guidance for Y-mAbs Therapeutics (YMAB)?
There have been no specific sales or earnings guidance reported for Y-mAbs Therapeutics in recent months.
Browse guidance and forecast on all stocks.